Chemical formula: C₉H₉Cl₂N₃O Molecular mass: 246.093 g/mol PubChem compound: 3519
Guanfacine is indicated for:
Population group: only children (1 year - 12 years old) , adolescents (12 years - 18 years old)
Guanfacine is indicated for the treatment of attention deficit hyperactivity disorder (ADHD) in children and adolescents 6-17 years old for whom stimulants are not suitable, not tolerated or have been shown to be ineffective.
Guanfacine must be used as a part of a comprehensive ADHD treatment programme, typically including psychological, educational and social measures.
For this indication, competent medicine agencies globally authorize below treatments (click for details):
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
